loading
Research & Development
With incessant passion on R&D, we pursue the new value and differentiated product development.
Pipeline
New Drug
Indication Drug Discovery Preclinical Clinical Phase 1 Clinical Phase 2 Clinical Phase 3 Release
Obesity
Diabetes
IMD
(Incrementally Modified Drug)
Code Indication Research Pre-Clinical Clinical Study Marketing Authorization Release
DKF-MA102 Prostate cancer
DKF-MB101 Immuosuppression
DKF-MA201 Growth Hormone
DKF-MB201 Growth Hormone
DKF-313 Prostatic Hypertrophy
DKF-335 Osteoporosis
DKF-460 Dyslipidemia
Medical Devices
Code Indication Research Pre-Clinical Clinical Study Marketing Authorization Release
DKM-428 Skin protection
DKB-119 Tissue repair (Filler)
DKB-133 Tissue repair (Filler)